Advanced

PARLIAMENTARY WRITTEN QUESTION
(24 March 2025)

Question Asked

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of offering the RSV vaccination to people over the age of 65.

Asked by:
John Milne (Liberal Democrat)

Answer

The policy for the respiratory syncytial virus (RSV) programme is based on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), an independent expert advisory committee. That advice is provided to the Government to inform, develop, and make policy.

In 2023, RSV programmes for those aged over 65 years old and those aged over 75 years old were assessed by the JCVI for their potential impact and cost effectiveness. There was more certainty in the data available at the time to support a programme for those aged over 75 years old. Therefore, the JCVI advised a programme for older adults aged 75 years old and above. However, the JCVI did note that as more data accumulated, the impact and cost effectiveness for those aged over 65 years old could be kept under review.

The committee keeps all vaccine programmes under review and will continue to update its advice as new evidence emerges.


Answered by:
()

Contains Parliamentary information licensed under the Open Parliament Licence v3.0.